We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+27.94%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.4B
AUM Growth
+$6.4B
(+19%)
Cap. Flow
-$900M
Cap. Flow
% of AUM
-2.23%
Top 10 Holdings %
Top 10 Hldgs %
16.03%
Holding
2,489
New
261
Increased
810
Reduced
1,082
Closed
259
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$245M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$143M |
| 3 |
3M
MMM
|
+$142M |
| 4 |
Public Service Enterprise Group
PEG
|
+$108M |
| 5 |
KeyCorp
KEY
|
+$80.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$378M |
| 2 |
Kimberly-Clark
KMB
|
+$186M |
| 3 |
Altria Group
MO
|
+$141M |
| 4 |
AbbVie
ABBV
|
+$141M |
| 5 |
Pfizer
PFE
|
+$120M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.35% |
| 2 | Technology | 19% |
| 3 | Consumer Discretionary | 10.55% |
| 4 | Financials | 9.89% |
| 5 | Communication Services | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SKX
1301
DELISTED
Skechers
SKX
| $860K | ﹤0.01% |
27,417
-8,200
| -23% | -$235K |
|
1302
Cullen/Frost Bankers
CFR
$9.92B
| $859K | ﹤0.01% |
11,494
-318
| -3% | -$22.1K |
|
|
STAY
1303
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $859K | ﹤0.01% |
+76,757
| New | +$804K |
|
1304
Coda Octopus Group
CODA
$122M
| $858K | ﹤0.01% |
166,683
+72,548
| +77% | +$382K |
|
1305
Ennis
EBF
$541M
| $855K | ﹤0.01% |
47,143
-12,701
| -21% | -$224K |
|
1306
Pediatrix Medical
MD
$2.07B
| $845K | ﹤0.01% |
49,367
-21,081
| -30% | -$313K |
|
|
ALEX
1307
DELISTED
Alexander & Baldwin
ALEX
| $842K | ﹤0.01% |
69,061
+11,292
| +20% | +$133K |
|
1308
Black Hills Corp
BKH
$5.44B
| $841K | ﹤0.01% |
14,851
-496
| -3% | -$30K |
|
1309
Williams Companies
WMB
$87.8B
| $840K | ﹤0.01% |
44,160
-4,380
| -9% | -$81.5K |
|
|
SI
1310
DELISTED
Silvergate Capital Corporation
SI
| $840K | ﹤0.01% |
60,000
-60,000
| -50% | -$810K |
|
1311
CME Group
CME
$97.5B
| $839K | ﹤0.01% |
5,161
-47
| -0.9% | -$8.43K |
|
1312
Dover
DOV
$25.5B
| $836K | ﹤0.01% |
8,650
-483
| -5% | -$44.6K |
|
|
ETRN
1313
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $835K | ﹤0.01% |
100,457
+41,095
| +69% | +$324K |
|
|
SGI
1314
Somnigroup International
SGI
$13.7B
| $834K | ﹤0.01% |
46,380
-251,204
| -84% | -$3.6M |
|
1315
Coherent
COHR
$58B
| $831K | ﹤0.01% |
17,608
+712
| +4% | +$28.2K |
|
|
JHG
1316
DELISTED
Janus Henderson
JHG
| $831K | ﹤0.01% |
39,288
-3,188
| -8% | -$61.5K |
|
1317
Kodiak Sciences
KOD
$2.06B
| $830K | ﹤0.01% |
15,332
+7,814
| +104% | +$441K |
|
|
LM
1318
DELISTED
Legg Mason, Inc.
LM
| $826K | ﹤0.01% |
16,596
-1,233
| -7% | -$61.2K |
|
1319
NorthWestern Energy
NWE
$4.26B
| $823K | ﹤0.01% |
15,084
+276
| +2% | +$16K |
|
1320
Republic Bancorp
RBCAA
$1.84B
| $823K | ﹤0.01% |
25,172
+488
| +2% | +$15.4K |
|
1321
Zoom
ZM
$26.9B
| $820K | ﹤0.01% |
+3,233
| New | +$582K |
|
1322
Silgan Holdings
SLGN
$4.02B
| $816K | ﹤0.01% |
25,196
-896
| -3% | -$29.2K |
|
|
WBS
1323
DELISTED
Webster Financial
WBS
| $816K | ﹤0.01% |
28,531
+3,249
| +13% | +$86.1K |
|
1324
Mattel
MAT
$3.8B
| $810K | ﹤0.01% |
83,729
-9,667
| -10% | -$87.8K |
|
1325
Xeris Biopharma Holdings
XERS
$1.49B
| $798K | ﹤0.01% |
300,000
| – | – |
|
Similar funds
Federated Hermes's Q2 2020 Portfolio in Review
As of Q2 2020, Federated Hermes held 2,489 positions worth $40.4B, up 19% from $34B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2020 filing shows 261 new, 810 increased, 1,082 reduced and 259 closed positions. Its largest new stake was ZoomInfo Technologies: 1,084,200 shares worth $55.3M. The largest sale was Gilead Sciences, an estimated $378M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Discretionary.
- Federated Hermes's largest Q2 2020 buy was ZoomInfo Technologies: 1,084,200 shares worth $55.3M.
- Federated Hermes added most to IBM in Q2 2020, an estimated $245M increase.
- Federated Hermes's biggest Q2 2020 reduction was Gilead Sciences, cutting an estimated $378M.
- Federated Hermes fully exited Invesco in Q2 2020, selling an estimated $62.7M.
- Federated Hermes's ten largest holdings make up 16% of its $40.4B portfolio in Q2 2020.
- Federated Hermes opened 261 new positions and closed 259 in Q2 2020.
- Federated Hermes's portfolio value rose 19% quarter-over-quarter to $40.4B.
Based on Federated Hermes's 13F filing for Q2 2020, filed 13 Aug 2020.